Vicarious Surgical Reports Second Quarter 2023 Financial Results and Announces Clinical Plan and Regulatory Intent

Go back to Vicarious Surgical Reports Second Quarter 2023 Financial Results and Announces Clinical Plan and Regulatory Intent

Vicarious Surgical Inc. (RBOT) Misses Q2 EPS by 2c

July 27, 2023 4:36 PM EDT

Vicarious Surgical Inc. (NYSE: RBOT) reported Q2 EPS of ($0.16), $0.02 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Vicarious Surgical Inc. (RBOT) click here.

... More